Norman Wolmark, MD
Enriched profileProfessor of Surgery and Director of National Cancer Institute Cooperative Group Clinical Trials at UPMC Hillman Cancer Center · University of Pittsburgh
Norman Wolmark is Professor of Surgery and Director of National Cancer Institute Cooperative Group Clinical Trials at UPMC Hillman Cancer Center at University of Pittsburgh. OpenAlex indexes 933 publications with 124,155 citations (h-index 146); ClinicalTrials.gov lists 60 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Surgical Oncology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Norman Wolmark, MD, is Professor of Surgery and Director of National Cancer Institute Cooperative Group Clinical Trials at UPMC Hillman Cancer Center at University of Pittsburgh, School of Medicine, Department of Surgery. The public record shows 933 publications with 124,155 citations (h-index 146), centered on Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Colorectal Cancer Treatments and Studies. It also documents an investigator role on 60 registered clinical trials, industry payments reported by 1 companies, 6 NIH-funded awards (1985–2026).
- Most recent indexed publication: 2026 · Journal of clinical oncology
- Top research focus: Breast Cancer Treatment Studies
- 60 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 435.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 60 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 18 Oct 2026
1 company reported payments to CMS in program years 2023–2023. These are public disclosures, not judgments. The latest:
- Genentech USA, Inc.Program year20232 payments
NIH funding
Updated 18 Oct 2026
6 NIH research awards on record, funded 1985–2026 per NIH RePORTER. The latest:
- NRG Oncology Network Group Operations Center
Nrg Oncology Foundation, Inc.
FY2026$13,144,395U10CA180868
Congress activity
Updated 18 Oct 2026
273 congress contributions (2003–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract CT013: Whole-exome sequencing tumor-informed circulating tumor DNA detection after completion of neoadjuvant treatment predicts non-pCR and distant recurrence in patients with early triple-negative breast cancer (TNBC) — Results from a sub-study of the NSABP B-59/GBG-96-GeparDouze Trial
AACR Annual Meeting
AACR2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.
Journal of clinical oncology
Clinical Trial2026 - Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial.
Nature medicine
Clinical Trial2026 - Development and Validation of a Multimodal-Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer.
Cancer research communications
Article2026 - Headwinds in Breast Cancer Research: The Case for Pragmatic Radiotherapy De-escalation Studies.
Journal of clinical oncology
Article2026
Most-cited works
by citation count (OpenAlex)- 01A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerArticle6,280 citations2004
- 02
- 03
- 04Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerArticle5,360 citations2005
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/norman-wolmark-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ascopost.com/issues/june-3-2019-narratives-special-issue/asco-honors-leaders-in-cancer-care-with-2019-special-awards
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Other
hillmanresearch.upmc.edu/researchers/norman-wolmark-3e061f6d-91bd-de3e-c97f-3a70aa71
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hillmanresearch.upmc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
McGill University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - General Surgery Residency
McGill University and UPMC
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - Surgical Oncology Fellowship
Memorial Sloan Kettering Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - Research Fellowship
National Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - FACS
Fellow of the American College of Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - FRCSC
Fellow of the Royal College of Physicians and Surgeons of Canada
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗
Editorial & leadership roles
journal and society appointments- Chairman
NSABP Foundation
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Group Chair and Contact Principal Investigator
NRG Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Editorial Board
Journal of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - Editorial Board
JAMA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗ - Editorial Board
Lancet
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pitt.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →komen.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →surgery.pitt.edu ↗
- Distinguished Service Professor
University of Pittsburgh
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Secondary affiliations
appointments beyond the home institution- Professor and Chairman of Human Oncology
Drexel University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Udai Kammula, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Hope Rugo, MD
City of Hope
Dennis Slamon, MD
University of California, Los Angeles